journal article·2024-06Open access

Regulation of CTLs/Tregs via Highly Stable and Ultrasound‐Responsive Cerasomal Nano‐Modulators for Enhanced Colorectal Cancer Immunotherapy

Jinxia Zhang, Lihong Sun, Ling Jiang, Xinxin Xie, Yuan Wang, Ruiqi Wu, Qingshuang Tang, Suhui Sun, Shiwei Zhu, Xiaolong Liang, Ligang Cui

Advanced Science· Volume 11· Issue 22

Abstract

Abstract Immunotherapy is showing good potential for colorectal cancer therapy, however, low responsive rates and severe immune‐related drug side effects still hamper its therapeutic effectiveness. Herein, a highly stable cerasomal nano‐modulator (DMC@P‐Cs) with ultrasound (US)‐controlled drug delivery capability for selective sonodynamic‐immunotherapy is fabricated. DMC@P‐Cs’ lipid bilayer is self‐assembled from cerasome‐forming lipid (CFL), pyrophaeophorbid conjugated lipid (PL), and phospholipids containing unsaturated chemical bonds (DOPC), resulting in US‐responsive lipid shell. Demethylcantharidin (DMC) as an immunotherapy adjuvant is loaded in the hydrophilic core of DMC@P‐Cs. With US irradiation, reactive oxygen species (ROS) can be effectively generated from DMC@P‐Cs, which can not only kill tumor cells for inducing immunogenic cell death (ICD), but also oxidize unsaturated phospholipids‐DOPC to change the permeability of the lipid bilayers and facilitate controlled release of DMC, thus resulting in down‐regulation of regulatory T cells (Tregs) and amplification of anti‐tumor immune responses. After intravenous injection, DMC@P‐Cs can efficiently accumulate at the tumor site, and local US treatment resulted in 94.73% tumor inhibition rate. In addition, there is no detectable systemic toxicity. Therefore, this study provides a highly stable and US‐controllable smart delivery system to achieve synergistical sonodynamic‐immunotherapy for enhanced colorectal cancer therapy.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · RNA Interference and Gene Delivery · Immunotherapy and Immune Responses

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Institute of Medical Technology Peking University Health Science Center Beijing 100010 P. R. China

Department of Ultrasound Peking University Third Hospital Beijing 100191 P. R. China

Funding

National Natural Science Foundation of China · Peking University Third Hospital · Natural Science Foundation of Beijing Municipality

References (48)

Show source-provided references
1. 10.1038/nrc323910.1038/nrc3239 ↗
2. 10.1126/science.120348610.1126/science.1203486 ↗
3. 10.1038/nnano.2017.5210.1038/nnano.2017.52 ↗
4. 10.1038/s41577-019-0269-610.1038/s41577-019-0269-6 ↗
5. 10.1038/s41571-019-0308-z10.1038/s41571-019-0308-z ↗
6. 10.1038/nature1395410.1038/nature13954 ↗
7. 10.1038/nature1401110.1038/nature14011 ↗
8. 10.1038/s41577-019-0232-610.1038/s41577-019-0232-6 ↗
9. 10.1038/nrd368310.1038/nrd3683 ↗
10. 10.1038/nrd.2018.14810.1038/nrd.2018.148 ↗
11. 10.1038/s41568-019-0186-910.1038/s41568-019-0186-9 ↗
12. 10.1038/nbt.418110.1038/nbt.4181 ↗
13. 10.1021/acs.accounts.0c0033910.1021/acs.accounts.0c00339 ↗
14. 10.1038/s41467-022-32160-z10.1038/s41467-022-32160-z ↗
15. 10.1126/scitranslmed.aan368210.1126/scitranslmed.aan3682 ↗
16. 10.1038/s41467-021-23194-w10.1038/s41467-021-23194-w ↗
17. 10.1038/s41467-021-21047-010.1038/s41467-021-21047-0 ↗
18. 10.1002/adma.20200755710.1002/adma.202007557 ↗
19. 10.1016/j.bioactmat.2022.02.02610.1016/j.bioactmat.2022.02.026 ↗
20. 10.1016/j.jconrel.2014.05.03610.1016/j.jconrel.2014.05.036 ↗
21. 10.1016/j.nano.2013.06.01110.1016/j.nano.2013.06.011 ↗
22. 10.1021/acsnano.5b0437810.1021/acsnano.5b04378 ↗
23. 10.1126/science.109583310.1126/science.1095833 ↗
24. 10.1016/j.colsurfb.2020.11118910.1016/j.colsurfb.2020.111189 ↗
25. 10.1021/nn500216y10.1021/nn500216y ↗
26. 10.1016/0959-8049(95)00050-X10.1016/0959-8049(95)00050-X ↗
27. 10.1038/ni.339010.1038/ni.3390 ↗
28. 10.1002/mabi.20130040210.1002/mabi.201300402 ↗
29. 10.1021/acs.biomac.6b0070510.1021/acs.biomac.6b00705 ↗
30. 10.1038/nrd163210.1038/nrd1632 ↗
31. 10.1158/1078-0432.CCR-06-244310.1158/1078-0432.CCR-06-2443 ↗
32. 10.1080/0265673060058295610.1080/02656730600582956 ↗
33. 10.1007/s11095-010-0154-210.1007/s11095-010-0154-2 ↗
34. 10.1038/nrd261410.1038/nrd2614 ↗
35. 10.1016/j.cis.2013.11.01410.1016/j.cis.2013.11.014 ↗
36. 10.1039/b926367e10.1039/b926367e ↗
37. 10.3109/17435390.2010.54695010.3109/17435390.2010.546950 ↗
38. 10.1016/j.colsurfb.2016.09.03310.1016/j.colsurfb.2016.09.033 ↗
39. 10.7150/thno.3676210.7150/thno.36762 ↗
40. 10.1152/physiol.00046.200610.1152/physiol.00046.2006 ↗
41. 10.1089/15230860276059891810.1089/152308602760598918 ↗
42. 10.1128/MCB.20.15.5680-5689.200010.1128/MCB.20.15.5680-5689.2000 ↗
43. 10.1016/j.biomaterials.2021.12078710.1016/j.biomaterials.2021.120787 ↗
44. 10.1158/2159-8290.CD-18-036710.1158/2159-8290.CD-18-0367 ↗
45. 10.1038/ni.270310.1038/ni.2703 ↗
46. 10.1038/s41577-018-0044-010.1038/s41577-018-0044-0 ↗
47. 10.1002/chem.20130251810.1002/chem.201302518 ↗
48. 10.1038/nm.293310.1038/nm.2933 ↗